Author Details

Name: Mattias Mandorfer

Affiliations: Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Austria; Barcelona Hepatic Hemodynamic Lab, Liver Unit, Hospital Clínic, Universitat de Barcelona, Spain.

Publications

• Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis.

• Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD.

• Refining the Baveno VII criteria for clinically significant portal hypertension: an individual-patient data meta-analysis.

• Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study.

• Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

• Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding.

• Non-invasive tests for clinically significant portal hypertension after HCV cure.

• Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease.

• Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.